niacinamide has been researched along with Disbacteriosis in 3 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This crucial role can be attributed to the gut microflora and its ability to shape human behavior and development by mediating the bioavailability of metabolites." | 2.66 | Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects. ( Anton, E; Ciobica, A; Cojocariu, RO; Dhunna, N; Doroftei, B; Grab, D; Ilie, OD; Maftei, R; McKenna, J; Simionescu, G, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Niño-Narvión, J | 1 |
| Rojo-López, MI | 1 |
| Martinez-Santos, P | 1 |
| Rossell, J | 1 |
| Ruiz-Alcaraz, AJ | 1 |
| Alonso, N | 1 |
| Ramos-Molina, B | 1 |
| Mauricio, D | 1 |
| Julve, J | 1 |
| Doroftei, B | 1 |
| Ilie, OD | 1 |
| Cojocariu, RO | 1 |
| Ciobica, A | 1 |
| Maftei, R | 1 |
| Grab, D | 1 |
| Anton, E | 1 |
| McKenna, J | 1 |
| Dhunna, N | 1 |
| Simionescu, G | 1 |
| Blacher, E | 1 |
| Bashiardes, S | 1 |
| Shapiro, H | 1 |
| Rothschild, D | 1 |
| Mor, U | 1 |
| Dori-Bachash, M | 1 |
| Kleimeyer, C | 1 |
| Moresi, C | 1 |
| Harnik, Y | 1 |
| Zur, M | 1 |
| Zabari, M | 1 |
| Brik, RB | 1 |
| Kviatcovsky, D | 1 |
| Zmora, N | 1 |
| Cohen, Y | 1 |
| Bar, N | 1 |
| Levi, I | 1 |
| Amar, N | 1 |
| Mehlman, T | 1 |
| Brandis, A | 1 |
| Biton, I | 1 |
| Kuperman, Y | 1 |
| Tsoory, M | 1 |
| Alfahel, L | 1 |
| Harmelin, A | 1 |
| Schwartz, M | 1 |
| Israelson, A | 1 |
| Arike, L | 1 |
| Johansson, MEV | 1 |
| Hansson, GC | 1 |
| Gotkine, M | 1 |
| Segal, E | 1 |
| Elinav, E | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Impact of the Combined Treatment of Curcumin and Resveratrol Liposomed Polyphenols With G04CB02 on the Clinical Improvement of ALS Patients[NCT04654689] | Phase 2 | 90 participants (Actual) | Interventional | 2021-11-20 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for niacinamide and Disbacteriosis
| Article | Year |
|---|---|
NAD+ Precursors and Intestinal Inflammation: Therapeutic Insights Involving Gut Microbiota.
Topics: Animals; Dysbiosis; Gastrointestinal Microbiome; Humans; Inflammation; Mammals; NAD; Niacinamide | 2023 |
Minireview Exploring the Biological Cycle of Vitamin B3 and Its Influence on Oxidative Stress: Further Molecular and Clinical Aspects.
Topics: Betacoronavirus; Coronavirus Infections; COVID-19; Dysbiosis; Gastrointestinal Microbiome; Humans; N | 2020 |
1 other study available for niacinamide and Disbacteriosis
| Article | Year |
|---|---|
Potential roles of gut microbiome and metabolites in modulating ALS in mice.
Topics: Akkermansia; Amyotrophic Lateral Sclerosis; Animals; Anti-Bacterial Agents; Disease Models, Animal; | 2019 |